Dotarem Received FDA Approval For MRIs of Central Nervous System
21 March 2013
What’s New: FDA has approved Dotarem (gadoterate meglumine) to be used as a contrast agent in MRIs of various parts of the central nervous system such as spine and brain. Important Detail: The Food and Drug Administration of the United States said that the imaging agent has been approved for use among people 2 years [...]


Recent Comments